| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine (S.B., K.A.S., T.H.M.), Baltimore, Maryland 21205; and Molecular Pharmacology Research Center, Department of Medicine, Tufts-New England Medical Center (A.S.K.), Boston, Massachusetts 02111
Address all correspondence and requests for reprints to: Dr. S. Bi, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross 618, Baltimore, Maryland 21205. E-mail: sbi{at}jhmi.edu.
Although cholecystokinin A (CCK-A) receptors (CCK-AR) mediate the feeding inhibitory actions of CCK in both rats and mice, the absence of CCK-AR results in species-specific phenotypes. The lack of CCK-AR in Otsuka Long-Evans Tokushima fatty (OLETF) rats results in hyperphagia and obesity. We have suggested that demonstrated increases in meal size and elevated levels of dorsomedial hypothalamic (DMH) neuropeptide Y (NPY) gene expression may contribute to this phenotype. In contrast to OLETF rats, CCK-AR–/– mice have normal total daily food intake and do not develop obesity. To assess the basis underlying the different phenotypes in rats and mice lacking CCK-AR, we characterized meal patterns in CCK-AR–/– mice and determined whether CCK-AR–/– mice exhibited an alteration in DMH NPY gene expression. We demonstrate that although CCK-AR–/– mice show a similar dysregulation in meal size as OLETF rats, they do not have an elevation in DMH NPY mRNA expression levels. In fact, intact mice have no CCK-AR in the DMH. Furthermore, in intact rats, NPY and CCK-AR are colocalized in DMH neurons, and parenchymal injection of CCK into the DMH reduces food intake and down-regulates DMH NPY mRNA expression. These results suggest that although CCK-AR plays a role in the mediation of CCK actions in the control of meal size in both rats and mice, CCK-AR seems to contribute to modulating DMH NPY levels only in rats. The deficit in CCK’s action in the control of DMH NPY gene expression may play a major role in the obese phenotype in OLETF rats.
This article has been cited by other articles:
 |
|
 |
|
  T. Shimazoe, M. Morita, S. Ogiwara, T. Kojiya, J. Goto, M. Kamakura, T. Moriya, K. Shinohara, S. Takiguchi, A. Kono, et al. Cholecystokinin-A receptors regulate photic input pathways to the circadian clock FASEB J, May 1, 2008; 22(5): 1479 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-M. Lo, L. C. Samuelson, J. B. Chambers, A. King, J. Heiman, R. J. Jandacek, R. R. Sakai, S. C. Benoit, H. E. Raybould, S. C. Woods, et al. Characterization of mice lacking the gene for cholecystokinin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R803 - R810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bi, J. Chen, R. R. Behles, J. Hyun, A. S. Kopin, and T. H. Moran Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R55 - R63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Clerc, M. G. Coll Constans, H. Lulka, S. Broussaud, C. Guigne, S. Leung-Theung-Long, C. Perrin, C. Knauf, C. Carpene, L. Penicaud, et al. Involvement of Cholecystokinin 2 Receptor in Food Intake Regulation: Hyperphagia and Increased Fat Deposition in Cholecystokinin 2 Receptor-Deficient Mice Endocrinology, March 1, 2007; 148(3): 1039 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Clee and A. D. Attie The Genetic Landscape of Type 2 Diabetes in Mice Endocr. Rev., February 1, 2007; 28(1): 48 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Arumugam, D. Fleenor, and M. Freemark Lactogenic and Somatogenic Hormones Regulate the Expression of Neuropeptide Y and Cocaine- and Amphetamine-Regulated Transcript in Rat Insulinoma (INS-1) Cells: Interactions with Glucose and Glucocorticoids Endocrinology, January 1, 2007; 148(1): 258 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Szelenyi Neuronal CCK and thermoregulation: two receptors with different functions Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R109 - R111. [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Whited, D. Thao, K. C. K. Lloyd, A. S. Kopin, and H. E. Raybould Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G156 - G162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blumberg, D. Haba, M. Schroeder, G. P. Smith, and A. Weller Independent ingestion and microstructure of feeding patterns in infant rats lacking CCK-1 receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R208 - R218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hajnal, M. Covasa, and N. T. Bello Altered taste sensitivity in obese, prediabetic OLETF rats lacking CCK-1 receptors Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1675 - R1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Darcel, G. Fromentin, H. E. Raybould, S. Gougis, D. W. Gietzen, and D. Tome Fos-Positive Neurons Are Increased in the Nucleus of the Solitary Tract and Decreased in the Ventromedial Hypothalamus and Amygdala by a High-Protein Diet in Rats J. Nutr., June 1, 2005; 135(6): 1486 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Levin and C. M. Patterson Exercising the Obese Brain: Resetting the Defended Body Weight Endocrinology, April 1, 2005; 146(4): 1674 - 1675. [Full Text] [PDF]
|
|
|
|
|
|
S. Bi, K. A. Scott, J. Hyun, E. E. Ladenheim, and T. H. Moran Running Wheel Activity Prevents Hyperphagia and Obesity in Otsuka Long-Evans Tokushima Fatty Rats: Role of Hypothalamic Signaling Endocrinology, April 1, 2005; 146(4): 1676 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C. De Jonghe, A. Hajnal, and M. Covasa Increased oral and decreased intestinal sensitivity to sucrose in obese, prediabetic CCK-A receptor-deficient OLETF rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R292 - R300. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
